NCT04081701 2025-11-21
DOMINO-START
Weill Medical College of Cornell University
Phase 4 Recruiting
Clinical Trials
14 trialsNCT07034859 2025-06-24
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
National Taiwan University Hospital
Phase 4 Enrolling by invitation
NCT05822817 2025-06-08
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
Peking Union Medical College Hospital
Phase 4 Completed
NCT06679816 2025-01-14
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Beijing Tiantan Hospital
Phase 4 Recruiting
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT02351700 2021-10-21
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
St. Joseph's Hospital and Medical Center, Phoenix
Phase 4 Completed
NCT01861717 2021-09-30
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
Saint John's Cancer Institute
Phase 4 Terminated
NCT04785222 2021-03-05
Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor
Chiang Mai University
Phase 4 Unknown
NCT03014687 2018-08-15
POET
St. Joseph's Hospital and Medical Center, Phoenix
Phase 4 Recruiting
NCT03132259 2017-05-30
Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach
Mahidol University
Phase 4 Unknown
NCT00376064 2017-03-06
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
Phase 4 Completed
NCT02549768 2016-10-12
Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Pontificia Universidad Catolica de Chile
Phase 4 Unknown
NCT01371643 2016-08-29
Surgical Debulking of Pituitary Adenomas
NYU Langone Health
Phase 4 Completed
NCT00461149 2007-04-17
HDacro
Federico II University
Phase 4 Completed